Drugs / H1ssF
last change Aug 2026 re-read 2 minutes ago

H1ssF

Vaccine

Developed for
influenza
Investigated by
University of Minnesota

Trials 1 · a red edge is where a trial was stopped

20272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07340047 Aug 2026 → Mar 2028 expected influenza University of Minnesota Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as H1ssF ClinicalTrials.gov intervention name — accepted as the source's own label NCT07340047
Modality Vaccine “Experimental influenza vaccineNCT07340047